These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 826595)

  • 1. Role of activated macrophages in resistance of mice to infection with Trypanosoma cruzi.
    Williams DM; Sawyer S; Remington JS
    J Infect Dis; 1976 Dec; 134(6):610-23. PubMed ID: 826595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi: T-cell-dependent mechanisms of resistance during chronic infection.
    Rottenberg ME; Cardoni RL; Sinagra A; Riarte A; Rodriguez Nantes I; Lauricella M; Segura EL
    Exp Parasitol; 1991 Aug; 73(2):127-36. PubMed ID: 1909649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian Target of Rapamycin Inhibition in
    Rojas Márquez JD; Ana Y; Baigorrí RE; Stempin CC; Cerban FM
    Front Immunol; 2018; 9():313. PubMed ID: 29515594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).
    Silva JS; Twardzik DR; Reed SG
    J Exp Med; 1991 Sep; 174(3):539-45. PubMed ID: 1908509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
    Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
    Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challege in vivo.
    Hoff R
    J Exp Med; 1975 Aug; 142(2):299-311. PubMed ID: 806649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
    Nunes MP; Andrade RM; Lopes MF; DosReis GA
    J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in microbicidal activities of human macrophages against Toxoplasma gondii and Trypanosoma cruzi.
    Israelski DM; Araujo FG; Wachtel JS; Heinrichs L; Remington JS
    Infect Immun; 1990 Jan; 58(1):263-5. PubMed ID: 2403533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
    Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
    Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 mediates susceptibility to Trypanosoma cruzi infection.
    Reed SG; Brownell CE; Russo DM; Silva JS; Grabstein KH; Morrissey PJ
    J Immunol; 1994 Oct; 153(7):3135-40. PubMed ID: 8089491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect of the 4-5S immune RNA against Trypanosoma cruzi infection in mice.
    Bertolini MC; De Lucca FL
    Trop Med Parasitol; 1985 Sep; 36(3):131-4. PubMed ID: 2417303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Signaling Lymphocytic Activation Molecule Family 1 (SLAMF1) receptor with Trypanosoma cruzi is strain-dependent and affects NADPH oxidase expression and activity.
    Poveda C; Herreros-Cabello A; Callejas-Hernández F; Osuna-Pérez J; Maza MC; Chillón-Marinas C; Calderón J; Stamatakis K; Fresno M; Gironès N
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008608. PubMed ID: 32925918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice.
    Aliberti JC; Machado FS; Gazzinelli RT; Teixeira MM; Silva JS
    Infect Immun; 1999 Jun; 67(6):2810-4. PubMed ID: 10338485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation.
    La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC
    Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
    Silva JS; Morrissey PJ; Grabstein KH; Mohler KM; Anderson D; Reed SG
    J Exp Med; 1992 Jan; 175(1):169-74. PubMed ID: 1730915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi.
    De Titto EH; Catterall JR; Remington JS
    J Immunol; 1986 Aug; 137(4):1342-5. PubMed ID: 3525677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA; Fernández MA; Fresno M
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.